Paraoxonase and arylesterase activities in fibromyalgia

REFERENCES

• Ozgocmen S. New strategies in evaluation of therapeutic efficacy in fibromyalgia syndrome. Curr Pharm Des 2006; 12: 67–71.
   PubMed Web of Science ®Google Scholar
• Altindag O, Celik H. Total antioxidant capacity and the severity of the pain in patients with fibromyalgia. Redox Report 2006; 11: 131–135.
   PubMed Web of Science ®Google Scholar
• Bagis S, Tamer L, Sahin G et al. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int 2005; 25: 188–190.
   Google Scholar
• Ozgocmen S, Ozyurt H, Sogut S, Akyol O, Ardicoglu O, Yildizhan H. Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int 2006; 26: 598–603.
   PubMed Web of Science ®Google Scholar
• Rowat SC. Paraoxonase/MCS. Environ Health Perspect 1999; 107: 395.
   Web of Science ®Google Scholar
• Pall ML. Common etiology of posttraumatic stress disorder, fibromyalgia, chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric oxide/peroxynitrite. Med Hypotheses 2001; 57: 139–145.
   PubMed Web of Science ®Google Scholar
• Hotopf M, Mackness MI, Nikolaou V et al. Paraoxonase in Persian Gulf War veterans. J Occup Environ Med 2003; 45: 668–675.
   PubMed Web of Science ®Google Scholar
• Aslan M, Kosecik M, Horoz M, Selek S, Celik H, Erel O. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia. Atherosclerosis 2007; 191: 397–402.
   PubMed Web of Science ®Google Scholar
• Serdar Z, Asian K, Dirican M, Sarandol E, Yesilbursa D, Serdar A. Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. Clin Biochem 2006; 39: 794–803.
   PubMed Web of Science ®Google Scholar
• Stadtman ER, Levine RL. Protein oxidation. Ann NY Acad Sci 2000; 899: 191–208.
   PubMed Web of Science ®Google Scholar
• Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381–1478.
   PubMed Web of Science ®Google Scholar
• Schwenke DC. Antioxidants, dietary fat saturation, lipoprotein oxidation and atherogenesis. Nutrition 1998; 12: 377–379.
   Web of Science ®Google Scholar
• La Du BN. Is paraoxonase-3 another hdl-associated protein protective against atherosclerosis? Arterioscler Thromb Vasc Biol 2001; 21: 467–468.
   PubMed Web of Science ®Google Scholar
• Aviram M, Rosenblat M. Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences. Curr Opin Lipidol 2005; 16: 393–399.
   PubMed Web of Science ®Google Scholar
• Katz RS, Wolfe F, Michaud K. Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum 2006; 54: 169–176.
   PubMedGoogle Scholar
• Eckerson HW, Wyte CM, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983; 35: 1126–1138.
   PubMed Web of Science ®Google Scholar
• Haagen L, Brock A. A new automated method for phenotyping arylesterase (EC 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 1992; 30: 391–395.
   PubMedGoogle Scholar
• Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112–119.
   PubMed Web of Science ®Google Scholar
• Nourooz-Zadeh J. Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. Methods Enzymol 1999; 300: 58–62.
   PubMed Web of Science ®Google Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70–77.
   PubMed Web of Science ®Google Scholar
• Hu ML, Louie S, Cross CE, Motchnik P, Halliwell B. Antioxidant protection against hyochlorous acid in human plasma. J Lab Clin Med 1993; 121: 257–262.
   PubMed Web of Science ®Google Scholar
• Witztum JL, Steinberg D. The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc Med 2001; 11: 93–102.
   PubMed Web of Science ®Google Scholar
• Haidara MA, Yassin HZ, Rateb M, Ammar H, Zorkani MA. Role of oxidative stress in development of cardiovascular complications in diabetes mellitus. Curr Vasc Pharmacol 2006; 4: 215–227.
   PubMedGoogle Scholar
• Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, Desouza CA. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obes Res 2006; 14: 2127–2131.
   Google Scholar
• Arlt S, Kontush A, Muller-Thomsen T, Beisiegel U. [Lipid peroxidation as a common pathomechanism in coronary heart disease and Alzheimer disease]. Z Gerontol Geriatr 2001; 34: 461–465.
   PubMed Web of Science ®Google Scholar
• Ali M. The cause of fibromyalgia: the respiratory-to-fermentative shift (the Dys0x State) in ATP production. J Integral Med 2003; 8: 135–140.
   Google Scholar
• Gur M, Aslan M, Yildiz A et al. Paraoxonase and arylesterase activities in coronary artery disease. Eur J Clin Invest 2006; 36: 779–787.
   PubMed Web of Science ®Google Scholar
• Aslan M, Nazligul Y, Horoz M et al. Serum paraoxonase-1 activity in Helicobacter pylori infected subjects. Atherosclerosis 2007; In press.
   Google Scholar
• Vent FF, Celik H, Yazgan P, Erel O, Geyikli I. Paraoxonase-1 activity as a marker of atherosclerosis is not associated with low bone mineral density in healthy postmenopausal women. Arch Gynecol Obstet 2007; 275: 353–359.
   PubMedGoogle Scholar
• Sumegova K, Blazicek P, Waczulikova I, Zitnanova I, Durackova Z. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks. Acta Biochim Pol 2006; 53: 783–787.
   PubMed Web of Science ®Google Scholar
• Altindag O, Erel O, Aksoy N, Selek S, Celik H, Karaoglanoglu M. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol Int 2007; 27: 339–344.
   PubMed Web of Science ®Google Scholar